Cargando…
Tegaserod for the Treatment of Irritable Bowel Syndrome
Background: Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C). Objective: The authors provide the reader with a bette...
Autores principales: | Madia, Valentina Noemi, Messore, Antonella, Saccoliti, Francesco, Tudino, Valeria, De Leo, Alessandro, De Vita, Daniela, Bortolami, Martina, Scipione, Luigi, Pindinello, Ivano, Costi, Roberta, Di Santo, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579269/ https://www.ncbi.nlm.nih.gov/pubmed/31518227 http://dx.doi.org/10.2174/1871523018666190911121306 |
Ejemplares similares
-
Analytical Characterization of an Inulin-Type Fructooligosaccharide from Root-Tubers of Asphodelus
ramosus L
por: Madia, Valentina Noemi, et al.
Publicado: (2021) -
Recent Advances in Recovery of Lycopene from Tomato Waste: A Potent Antioxidant with Endless Benefits
por: Madia, Valentina Noemi, et al.
Publicado: (2021) -
Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents
por: Madia, Valentina Noemi, et al.
Publicado: (2021) -
Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site
por: Madia, Valentina Noemi, et al.
Publicado: (2023) -
New Pyrimidine and Pyridine Derivatives as Multitarget
Cholinesterase Inhibitors: Design, Synthesis, and In Vitro and In Cellulo Evaluation
por: Bortolami, Martina, et al.
Publicado: (2021)